View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
January 4, 2022

Coronavirus company news summary – Sanger Sequencing detects SAR-CoV-2 variants – Australian regulator to assess rise in Covid-19 test costs

By Vishnu Priyan

Milford Molecular Diagnostics Laboratory’s Sanger Sequencing is claimed to detect all known SARS-CoV-2 variants of concern and interest, including Omicron and Delta. Director Sin Hang Lee said that the high complexity CLIA-certified laboratory offers the diagnostic test to patients as well as the healthcare providers directly. Milford is said to be the only lab in the US to provide this test.

The Australian Competition and Consumer Commission (ACCC) has contacted Covid-19 rapid antigen test kit suppliers to check the pricing levels in the market. The antitrust regulator noted that it will analyse the data obtained from suppliers, retailers as well as the public to determine any possible misconduct. Till date, more than a dozen of rapid antigen test kits are approved for use in the country with most of them from China.

Scientists at the University of Illinois Chicago (UIC) have developed a high-quality assay that can be utilised in at-home tests for quick screening of Covid-19. According to preclinical data, testing with the new assay can potentially be as good as the laboratory-based polymerase chain reaction (PCR) tests. The test is required to be validated in additional studies assessing more number of patient samples.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network